Huperzine-A

non-nutrient/non-botanical

What is it

Huperzine A is a naturally occurring alkaloid isolated from the Chinese club moss Huperzia serrata (also called Lycopodium serratum). It is a potent and selective inhibitor of acetylcholinesterase and is used in supplements for cognitive support, with the strongest research focused on Alzheimer's disease.

How it works

Huperzine A's primary mechanism is reversible inhibition of acetylcholinesterase, the enzyme that breaks down acetylcholine in synapses. By preventing acetylcholine breakdown, huperzine A increases the availability of this important neurotransmitter, which is critically involved in learning, memory, and cognitive function. This mechanism is similar to that of approved Alzheimer's drugs like donepezil but with greater potency per milligram. Research suggests huperzine A also has additional neuroprotective effects independent of its cholinesterase inhibition. It blocks NMDA receptors at high concentrations, which may protect against excitotoxic injury. It also has antioxidant effects and may protect against beta-amyloid toxicity in laboratory models. Clinical trials of huperzine A in Alzheimer's disease, primarily conducted in China, have suggested improvements in cognitive function, behavior, and daily living activities. However, evidence quality varies and Western trials have shown less consistent benefits. Effects in healthy individuals or for general memory enhancement are less well established.

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Alzheimer's disease cognitive symptoms

Grade C

Moderate evidence

Chinese clinical trials suggest huperzine A improves cognitive function and behavioral measures in mild-to-moderate Alzheimer's disease. Western evidence is less robust; not approved as a treatment in the US or Europe.

Vascular dementia

Grade C

Moderate evidence

Trials suggest possible cognitive benefits in vascular dementia, though evidence is less extensive than for Alzheimer's.

Mild cognitive impairment

Grade D

Mixed evidence

Some studies suggest possible benefit in MCI, but evidence is mixed and inconsistent.

Healthy memory enhancement

Grade D

Mixed evidence

Limited evidence for cognitive enhancement in healthy individuals; popular use for nootropic effects is not well supported by rigorous research.

Myasthenia gravis

Grade F

Limited evidence

Mechanistically plausible due to acetylcholinesterase inhibition, but clinical evidence in humans is limited.

2 commercial forms

Huperzine A capsules/tablets

Standard form with good oral bioavailability and relatively long half-life (10-14 hours).

The primary supplement form. Look for products specifying mcg content per serving.

Huperzia serrata extract

Standardized extract of the plant; check huperzine A content per dose.

Whole-plant extracts standardized to huperzine A content. Quality varies.

Dosage

Typical doses are 50-200 mcg per day. Clinical trials in Alzheimer's disease have used 200-500 mcg per day. There is no established RDA. Lower doses are recommended for general cognitive support to minimize side effects.

When and how to take it

Huperzine A is typically taken once daily in the morning. Splitting doses may help manage side effects but may interfere with sleep if taken in the evening due to cholinergic stimulation. Some practitioners recommend cycling huperzine A (e.g., 4-8 weeks on, 1-2 weeks off) to maintain effectiveness and minimize tolerance. Cognitive effects may be noticeable within days to weeks.

Safety

Huperzine A is generally well tolerated at typical supplement doses. Side effects related to acetylcholinesterase inhibition can include nausea, vomiting, diarrhea, sweating, increased salivation, muscle twitching, slowed heart rate, and insomnia. These effects are dose-dependent and resemble those of approved cholinesterase inhibitor medications. Long-term safety data are limited.

Who should be cautious

Avoid in pregnancy and breastfeeding due to insufficient safety data. People taking other cholinesterase inhibitors (Alzheimer's medications) should not use huperzine A. People with bradycardia (slow heart rate), epilepsy, asthma, GI obstruction, or peptic ulcer disease should consult a clinician. People with cardiac conduction abnormalities should avoid use without medical supervision.

Interactions

Huperzine A may enhance the effects of cholinergic medications (including approved Alzheimer's drugs like donepezil and rivastigmine, and the glaucoma drug pilocarpine), potentially causing cholinergic toxicity. It may interact with anticholinergic medications by opposing their effects. May affect heart rhythm in combination with medications that slow heart rate. Caution with antiseizure medications.

Frequently asked questions

What does huperzine A do?⌄

Huperzine A inhibits the enzyme that breaks down acetylcholine, a neurotransmitter important for memory and learning. By preserving acetylcholine, it may enhance cognitive function, particularly in conditions involving cholinergic decline like Alzheimer's disease.

Is huperzine A FDA approved?⌄

No. Huperzine A is sold as a dietary supplement in the US but is not approved as a medication. In China, it has been used clinically for Alzheimer's disease for decades.

What are the side effects?⌄

Common side effects relate to enhanced cholinergic activity and include nausea, sweating, slowed heart rate, increased salivation, and muscle twitching. Most are dose-dependent.

Should I cycle huperzine A?⌄

Many practitioners recommend cycling (e.g., 4-8 weeks on, 1-2 weeks off) to maintain effectiveness and minimize potential receptor adaptation. Evidence for this practice is largely theoretical.

Can I take huperzine A with Alzheimer's medications?⌄

No. Combining huperzine A with prescription cholinesterase inhibitors (donepezil, rivastigmine, galantamine) can cause cholinergic toxicity. Coordinate with your clinician.

References

  • PubChem: Huperzine A — PubChem link
  • Wikidata: Huperzine A — Wikidata link

Track Huperzine-A with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.